Putting contract research organisations on the radar

Area of Science:

• Pharmaceutical industry
• Clinical research ethics
• Global health

Background:

• Pharmaceutical companies are increasingly outsourcing clinical trial conduct to external organizations, known as contract research organizations.
• Clinical trials are also increasingly being conducted in non-traditional regions, primarily low- and middle-income countries, a practice termed offshoring.
• The convergence of outsourcing and offshoring in pharmaceutical research presents unique challenges.

Purpose of the Study:

• To examine the ethical implications of outsourcing and offshoring clinical trials.
• To identify the potential risks to participant welfare arising from these trends.
• To highlight the need for robust ethical oversight in globalized clinical research.

Main Methods:

• Literature review of current trends in pharmaceutical outsourcing and offshoring.
• Analysis of ethical frameworks relevant to clinical trial conduct.
• Case study examination of ethical challenges in international clinical research.

Main Results:

• Outsourcing and offshoring can lead to reduced oversight and increased vulnerability for trial participants.
• Variations in regulatory standards and cultural contexts across regions pose ethical dilemmas.
• Potential for exploitation exists due to economic disparities and differing ethical norms.

Conclusions:

• The combined trends of outsourcing and offshoring necessitate enhanced ethical vigilance and regulatory harmonization.
• Strengthening participant protection mechanisms is crucial in the context of globalized clinical trials.
• Further research is needed to develop best practices for ethical conduct in outsourced and offshored trials.